Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
Add more filters










Database
Language
Publication year range
1.
Int J Pharm ; 564: 492-498, 2019 Jun 10.
Article in English | MEDLINE | ID: mdl-31022505

ABSTRACT

The present study aimed to develop a photochemically stabilized formulation of dacarbazine [5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide; DTIC] for reducing the production of algogenic photodegradant (5-diazoimidazole-4-carboxamide; Diazo-IC). Photochemical properties of DTIC were characterized by UV-visible light spectral analysis, reactive oxygen species (ROS) assay, and photostability testing. A pharmacokinetic study was conducted after intravenous administration of DTIC formulations (1 mg-DTIC/kg) to rats. DTIC exhibited strong absorption in the UVA range, and photoirradiated DTIC exhibited marked ROS generation. Thus, DTIC had high photoreactive potential. After exposure of DTIC (1 mM) to simulated sunlight (250 W/m2) for 3 min, remaining DTIC and yielded Diazo-IC were estimated to be ca. 230 µM and 600 µM, respectively. The addition of radical scavenger (1 mM), including l-ascorbic acid, l-cysteine (Cys), l-histidine, D-mannitol, l-tryptophan, or l-tyrosine, to DTIC (1 mM) could attenuate DTIC photoreactions, and in particular, the addition of Cys to DTIC brought ca. 34% and 86% inhibition of DTIC photodegradation and Diazo-IC photogeneration, respectively. There were no significant differences in the calculated pharmacokinetic parameters of DTIC between DTIC and DTIC with Cys (0.67 mg/kg). From these findings, the supplementary use of Cys would be an effective approach to improve the photostability of DTIC with less production of Diazo-IC.


Subject(s)
Antineoplastic Agents, Alkylating , Azo Compounds/chemistry , Cysteine/chemistry , Dacarbazine , Free Radical Scavengers/chemistry , Imidazoles/chemistry , Light , Animals , Antineoplastic Agents, Alkylating/blood , Antineoplastic Agents, Alkylating/chemistry , Antineoplastic Agents, Alkylating/pharmacokinetics , Antineoplastic Agents, Alkylating/radiation effects , Dacarbazine/blood , Dacarbazine/chemistry , Dacarbazine/pharmacokinetics , Dacarbazine/radiation effects , Drug Stability , Male , Photolysis , Rats, Sprague-Dawley
2.
J Pharm Sci ; 104(10): 3501-9, 2015 Oct.
Article in English | MEDLINE | ID: mdl-26173629

ABSTRACT

The characterization of drugs' photodegradation kinetics is more accurately achieved by means of the recently developed Φ-order kinetics than by the zero-, first-, and/or second-order classical treatments. The photodegradation of anti-cancer dacarbazine (DBZ) in ethanol has been investigated and found to obey Φ-order kinetics when subjected to continuous and monochromatic irradiation of various wavelengths. Its photochemical efficiency was proven to be wavelength dependent in the 220-350 nm range, undergoing a 50-fold increase. Albeit this variation was well defined by a sigmoid pattern, the overall photoreactivity of DBZ was proven to depend also on the contributions of reactants and experimental attributes. The usefulness of DBZ to serve as a drug-actinometer has been investigated using the mathematical framework of Φ-order kinetics. It has been shown that DBZ in ethanol can represent a good candidate for reliable actinometry in the range 270-350 nm. A detailed and easy-to-implement procedure has been proposed for DBZ actinometry. This procedure could advantageously be implemented prior to the determination of the photodegradation quantum yields. This approach might be found useful for the development of many drug actinometers as alternatives to quinine hydrochloride.


Subject(s)
Antineoplastic Agents/chemistry , Antineoplastic Agents/radiation effects , Dacarbazine/chemistry , Dacarbazine/radiation effects , Algorithms , Ethanol/chemistry , Kinetics , Photochemistry , Photolysis , Quinine/chemistry , Solvents/chemistry , Spectrophotometry, Ultraviolet , Ultraviolet Rays
3.
J Control Release ; 210: 95-104, 2015 Jul 28.
Article in English | MEDLINE | ID: mdl-25982679

ABSTRACT

Glioblastoma is the most frequent primary malignant brain tumor in adults. Despite treatments including surgery, radiotherapy and chemotherapy by oral Temozolomide (TMZ), the prognosis of patients with glioblastoma remains very poor. We hypothesized that a polyethylene glycol dimethacrylate (PEG-DMA) injectable hydrogel would provide a sustained and local delivery of TMZ. The hydrogel photopolymerized rapidly (<2min) and presented a viscous modulus (≈10kPa). TMZ release kinetic presented two phases: a linear burst release of 45% of TMZ during the first 24h, followed by a logarithmic release of 20% over the first week. The in vivo tolerability study showed that the unloaded hydrogel did not induce apoptosis in mice brains nor increased microglial activation. In vivo, the anti-tumor efficacy of TMZ-hydrogel was evaluated on xenograft U87MG tumor-bearing nude mice. The tumor weight of mice treated with the photopolymerized TMZ hydrogel drastically decreased compared with all other groups. Higher apoptosis (located at the center of the tumor) was also observed. The present study demonstrates the potential of a photopolymerizable TMZ-loaded hydrogel to treat glioblastoma.


Subject(s)
Antineoplastic Agents, Alkylating/administration & dosage , Brain Neoplasms/drug therapy , Dacarbazine/analogs & derivatives , Drug Delivery Systems , Glioblastoma/drug therapy , Hydrogels/administration & dosage , Animals , Antineoplastic Agents, Alkylating/chemistry , Antineoplastic Agents, Alkylating/radiation effects , Antineoplastic Agents, Alkylating/therapeutic use , Apoptosis/drug effects , Brain Neoplasms/pathology , Cell Line, Tumor , Cell Proliferation/drug effects , Dacarbazine/administration & dosage , Dacarbazine/chemistry , Dacarbazine/radiation effects , Dacarbazine/therapeutic use , Delayed-Action Preparations/administration & dosage , Delayed-Action Preparations/chemistry , Delayed-Action Preparations/radiation effects , Delayed-Action Preparations/therapeutic use , Female , Glioblastoma/pathology , Humans , Hydrogels/chemistry , Hydrogels/radiation effects , Hydrogels/therapeutic use , Light , Methacrylates/chemistry , Methacrylates/radiation effects , Mice, Nude , Microglia/drug effects , Polyethylene Glycols/chemistry , Polyethylene Glycols/radiation effects , Temozolomide , Tumor Burden/drug effects
4.
Pharm Res ; 25(3): 598-604, 2008 Mar.
Article in English | MEDLINE | ID: mdl-17710513

ABSTRACT

PURPOSE: It has been reported that dacarbazine (DTIC) is photogenotoxic. The purpose of this study is to clarify the mechanism of photogenotoxicity induced by DTIC. MATERIALS AND METHODS: We examined DNA damage induced by UVA-irradiated DTIC using 32P-5'-end-labeled DNA fragments obtained from human genes. Formation of 8-oxo-7,8-dihydro-2'-deoxyguanosine (8-oxodG) in calf thymus DNA was measured by high performance liquid chromatograph with an electrochemical detector. Electron spin resonance (ESR) spin-trapping experiments were performed to detect radical species generated from UVA-irradiated DTIC. RESULTS: UVA-irradiated DTIC caused DNA damage at guanine residues, especially at the 5'-GGT-3' sequence in the presence of Cu(II) and also induced 8-oxodG generation in calf thymus DNA. DTIC-induced photodamage to DNA fragments was partially inhibited by catalase, whereas 8-oxodG formation was significantly increased by catalase. NaN3, a carbene scavenger, inhibited DNA damage and 8-oxodG formation in a dose-dependent manner, suggesting that carbene intermediates are involved. The ESR spin-trapping experiments demonstrated the generation of aryl radicals in the process of photodegradation of DTIC. CONCLUSION: Photoactivated DTIC generates the carbene and aryl radicals, which may induce both DNA adduct and 8-oxodG formation, resulting in photogenotoxicity. This study could provide an insight into the safe usage of DTIC.


Subject(s)
Antineoplastic Agents, Alkylating/toxicity , DNA Damage , DNA/drug effects , Dacarbazine/toxicity , Mutagens/toxicity , Ultraviolet Rays , 8-Hydroxy-2'-Deoxyguanosine , Animals , Antineoplastic Agents, Alkylating/chemistry , Antineoplastic Agents, Alkylating/radiation effects , Cattle , Chelating Agents/pharmacology , Copper/chemistry , DNA/chemistry , DNA Adducts , Dacarbazine/chemistry , Dacarbazine/radiation effects , Deoxyguanosine/analogs & derivatives , Deoxyguanosine/chemistry , Dose-Response Relationship, Drug , Electron Spin Resonance Spectroscopy , Free Radical Scavengers/pharmacology , Free Radicals/chemistry , Humans , Molecular Structure , Mutagens/chemistry , Mutagens/radiation effects , Nucleic Acid Conformation , Phenanthrolines/pharmacology , Photochemistry
5.
Chem Biol Interact ; 58(3): 319-31, 1986 Jun.
Article in English | MEDLINE | ID: mdl-3742646

ABSTRACT

Decomposition of the antitumor agent 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (DTIC, Dacarbazine) produces several potentially toxic compounds, the concentration of which depend on incubation parameters such as pH, temperature and illumination. The action of DTIC on chinese hamster ovary (CHO) cell clone formation in the dark (7-8-day incubation) reflects the slow formation of 2-azahypoxanthine. Hypoxanthine-guanine phosphoribosyltransferase (HGPRT, EC 2.4.2.8)-deficient cells are resistant to DTIC under these conditions, reflecting their inability to utilize 2-azahypoxanthine. The toxicity of DTIC in conventional survival experiments (1-2-h exposure to drug) is dependent upon illumination and is highly influenced by the pH of the medium. Toxicity of DTIC in these experiments appears to reflect rapid accumulation of the immediate photodecomposition product of the drug, 4-diazoimidazole-5-carboxamide (DZC), since HGPRT-deficient cells are not resistant to DTIC under these conditions. The biologically initiated pathway of DTIC action (enzymatic hydroxylation) has little, if any, role in the action of this agent toward cultured CHO cells.


Subject(s)
Dacarbazine/pharmacology , Fibroblasts/drug effects , Animals , Cell Line , Cricetinae , Cricetulus , Culture Techniques/methods , Dacarbazine/metabolism , Dacarbazine/radiation effects , Drug Resistance , Female , Hydrogen-Ion Concentration , Hypoxanthine Phosphoribosyltransferase/metabolism , Hypoxanthines/biosynthesis , Imidazoles/biosynthesis , Ovary , Photochemistry , Temperature
6.
Int J Cell Cloning ; 1(1): 24-32, 1983 Apr.
Article in English | MEDLINE | ID: mdl-6674387

ABSTRACT

Dacarbazine (DTIC) is an agent with clinical activity against human malignant melanoma. We have explored two methods for activating DTIC so it may be used in vitro in a human tumor cloning system. The activation of DTIC by white light was found to be a viable alternative to utilizing a microsome plus cofactor system for bioactivation. The microsome plus cofactor system itself actually caused some inhibition of tumor colony formation. Light activation of DTIC appears to be a reliable and simple method which allows testing of DTIC in an in vitro soft agar culture system.


Subject(s)
Dacarbazine/therapeutic use , Leukemia L1210/drug therapy , Light , Melanoma/drug therapy , Animals , Biotransformation , Cell Line , Clone Cells , Dacarbazine/metabolism , Dacarbazine/radiation effects , Drug Evaluation, Preclinical , Humans , Mice , Microsomes, Liver/enzymology
8.
Med Pediatr Oncol ; 2(3): 253-8, 1976.
Article in English | MEDLINE | ID: mdl-979914

ABSTRACT

Monolayer cultures of Chinese hamster ovary (CHO) cells take up the photo-decomposition products of DIC more readily than DIC itself. Dimethylamine, an immediate product of this degradative pathway, can ultimately become associated with the DNA, RNA, and protein of the cells as demonstrated by selective enzymatic degradation of macromolecules and isopycnic centrifugation. The relevance of these observations to mechanism studies of DIC is discussed.


Subject(s)
Dacarbazine , Dimethylamines , Triazenes , Animals , Cell Line , Cricetinae , DNA , Dacarbazine/metabolism , Dacarbazine/radiation effects , Dimethylamines/metabolism , Light , Macromolecular Substances , Triazenes/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...